Literature DB >> 6430321

Inhibition of human platelet aggregation by cyclandelate.

W E Van den Hoven, D W Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430321

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


× No keyword cloud information.
  6 in total

1.  The influence of cyclandelate on Ca++ translocation in human platelets.

Authors:  J W Akkerman; W E van den Hoven
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice.

Authors:  F de Halleux
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.

Authors:  M G Albizzati; S Bassi; E Calloni; M Sbacchi; R Piolti; L Frattola
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.

Authors:  I H De Leeuw; P Van Rooy; M Moeremans; M Driessens
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Inhibition of human platelet functions by cyclandelate.

Authors:  W E van den Hoven; D W Hall
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.